compounded semaglutide keedysville FDA Warns on Certain Forms of Compounded Semaglutide GLP-1 Care |

Lee, Ahmed O

Zepbound (FDA-Approved for Weight Management) Zepbound\u00AE (tirzepatide) injection is an FDA-approved dual GIP/GLP-1 receptor agonist manufactured by Eli Lilly and Company, indicated for chronic weight management in adults with obesity or overweight with at least one weight-related medical condition, used along with a reduced-calorie diet and increased physical activity

Noncompliance may result in significant legal and financial consequences, including regulatory action

however, these are investigational trial doses and do not constitute approved prescribing information

Long-term studies have shown sustained benefits and safety with appropriate medical monitoring, so be sure to use GLP-1 medication only under close supervision by your doctor